Cancer Center A Cancer Center Designated by
the National Cancer Institute

Andrew A. Shelton, M.D.

Parastomal Hernia Prevention With Strattice (PriSm)

Contact Information

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Primary Contact:

Moe Jalali (650) 724-4023
To view all clinical trials at Stanford, please see the Clinical Trials Directory.

Brief

The purpose of this study is to compare the clinical outcomes of patients undergoing surgery for a permanent abdominal wall ostomy with and without placement of Strattice fascial inlay, as measured by postoperative occurence of parastomal hernia.

Recruiting Status:

Recruiting

Stanford Recruiting Status:

Recruiting

Condition(s):

Intervention(s):

  • Device: Strattice Reconstructive Matrix
  • Procedure: Standard ostomy creation

Phase:

Phase 4

Eligibility

Ages Eligible for Study:

18 years to Any Age

Genders Eligible for Study:

Male and Female

Health of Volunteers:

People with the conditions listed in this trial can participate as controls.

Key Inclusion Criteria:

- adults

- need for permanent ileostomy or colostomy


Key Exclusion Criteria:

- history of hernia at new ostomy site

- has previously implanted surgical mesh at site of planned ostomy

- requires a temporary ostomy

- has need for multiple ostomies

- is receiving chronic immunosuppression therapy, has MELD score of > 17, has severe COPD, systemic infection, or known collagen disorder

- is bedridden or otherwise non-ambulatory


Additional Study Details

Official Title:

A Prospective, Multicenter, Randomized, Controlled, Third-Party Blinded Study of Strattice Fascial Inlay to Prevent Parastomal Hernia Formation in Patients Undergoing Surgery for Permanent Abdominal Wall Ostomies

Anticipated start date:

4/8/2009

Lead Sponsor:

LifeCell Corp

Study Type:

Interventional

Purpose:

Prevention

Allocation:

Randomized

Masking:

Double Blind

Control:

none

Assignment:

Parallel

Endpoints:

Efficacy

Primary Outcomes:

  • Occurrence of parastomal hernia [ Time Frame: 24 months ]

Secondary Outcomes:

  • Stoma Quality of Life [ Time Frame: Serially over 24 months ]
  • Stoma complications [ Time Frame: more than 1 month postoperatively ]
  • Stoma complications [ Time Frame: 30 days ]

Total Number to be Enrolled:

220

Total Number to be Enrolled at Stanford:

10

More Information

Trial Unique Id: SU-04102009-2220

Secondary ID(s):

  • LFC 2008.01.01
  • NCT00771407
  • VAR0035

Locations & Contacts

Stanford Locations & Contacts:

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Primary Contact:

Moe Jalali (650) 724-4023

Non-Stanford Locations:

The Stanford website does not have any locations outside of Stanford listed for this trial. You may want to check clinicaltrials.gov for posible additional locations.

This listing was last updated:

6/10/2009

PLEASE NOTE:

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician. If you do not have a primary care physician please feel free to call the SHC Physician Referral Service at (800) 756-9000 or send an email.

Stanford Medicine Resources:

Footer Links: